Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 39 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Gastric emptying test Clear all

Conditions: Gastroparesis
Interventions: EndoFLIP; Device
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Dyspepsia
Interventions: Alimetry, tVNS, Gastroduodenal Manometry; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastroparesis
Interventions: 13C-Spirulina Gastric Emptying Breath Test (GEBT), 13C-Spirulina Gastric Emptying Breath Test (GEBT) - repeat; Diagnostic Test
Lead sponsor: Cairn Diagnostics; Industry
Eligibility: 7 Years to 18 Years
Enrollment: 182 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Brentwood, Tennessee • Houston, Texas • Milwaukee, Wisconsin

Conditions: Weight Loss
Interventions: NSSM and GEBT; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 22 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastroparesis
Interventions: SmartPill Monitoring System; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 11
States / cities: Palo Alto, California • Largo, Florida • Miami, Florida + 8 more

Conditions: Obesity, Obesity, Morbid, Obesity Associated Disorder, Bariatric Surgery Candidate, Fistula, Gastric, Roux-en-y Anastomosis Site, Ulcer, Gastric, Abdominal Pain, Abdominal Obesity, Complication of Surgical Procedure, Complication of Treatment, Complication,Postoperative, Weight Gain, Weight Loss, Leak, Anastomotic, Delayed Gastric Emptying Following Procedure
Interventions: Primary Obesity Endoscopic Procedures, Endoscopic Revision of Bariatric Surgical Procedures, Bariatric Surgery Procedures, Endoscopic Sleeve Gastroplasty, Trans-oral Outlet Reduction, Intragastric Balloon, Primary obesity surgery endoluminal, Restorative obesity surgery endoluminal, Argon Plasma Coagulation, Gastroplasty with Endoscopic Myotomy, Bariatric Endoscopic Antral Myotomy, Pylorus Sparing Antral Myotomy, Aspiration Therapy; Procedure · Device
Lead sponsor: Christopher C. Thompson, MD, MSc; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gastroparesis
Interventions: Vagal Nerve Stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Obesity, Obesity, Morbid, Obesity, Primary, Metabolic Disease, Delayed Gastric Emptying Following Procedure
Interventions: PSAM Treatment Patients; Procedure
Lead sponsor: Christopher C. Thompson, MD, MSc; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Appetitive Behavior, Obesity, Diabetes Mellitus, Type 2
Interventions: Rice flour, Alternanoligosaccharide 15, Inulin, Waxy potato starch, Waxy potato starch + epigallocatechin gallate (EGCG), Chickpea flour + epigallocatechin gallate (EGCG); Other
Lead sponsor: Purdue University; Other
Eligibility: 22 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Gastroparesis
Interventions: Approved GEBT test meal; Diagnostic Test
Lead sponsor: Cairn Diagnostics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Brentwood, Tennessee

Conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior
Interventions: Isomaltooligosaccharides (IMOs), Xtend® sucromalt, Combination of IMOs and Xtend® sucromalt, Raw corn starch, Maltodextrin; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Dyspepsia
Interventions: [13C]-Spirulina platensis and 99mTc sulfur colloid; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior
Interventions: Pearl millet couscous - made in Senegal, Pearl millet couscous - made in USA, Pearl millet thick porridge, Wheat couscous, White rice; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Gastroparesis, Slow Transit Constipation, IBS
Interventions: Atmo Motility Gas Capsule System, SmartPill Monitoring System; Device
Lead sponsor: Atmo Biosciences Pty Ltd; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Boston, Massachusetts • Ann Arbor, Michigan

Conditions: Obesity, Weight Loss, Delayed Gastric Emptying Following Procedure, Obesity, Mild, Obesity, Morbid, Obesity; Excess Calories
Interventions: Bariatric Endoscopic Antral Myotomy; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gastroparesis
Interventions: 13C-Spirulina GEBT; Diagnostic Test
Lead sponsor: Cairn Diagnostics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Brentwood, Tennessee

Conditions: Does the Vagus Nerve Mediate the Effects of Xenin-25
Interventions: Graded Glucose Infusion with Placebo, Graded Glucose Infusion with GIP Alone, Graded Glucose Infusion with xenin-25 alone, Graded Glucose Infusion with GIP plus xenin-25, Meal Tolerance Test with Placebo, Meal Tolerance Test with xenin-25; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Disorders of Gut Brain Interaction
Interventions: Mannitol Solution 76 mOsm/L, Mannitol Solution 189 mOsm/L, Mannitol Solution 325 mOsm/L, Scintigraphy; Drug · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Diabetes Mellitus, Type 1
Interventions: Erythromycin lactobionate, Placebo IV, [13C]-Spirulina, Erythromycin Ethylsuccinate Suspension, Placebo Suspension; Drug
Lead sponsor: Adil Bharucha; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy
Interventions: Oxybutynin Chloride Gel, Placebo Gel; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Post-Bariatric Hypoglycemia
Interventions: Dietary Intervention, GLP-1 receptor agonist or Dual GIP/GLP-1 receptor agonist, Transoral Outlet Reduction (TORe); Behavioral · Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Atrial Fibrillation Ablation Procedure
Interventions: GI procedures; Procedure
Lead sponsor: Dhanunjaya Lakkireddy, MD, FACC; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Gastric Emptying, Gastroparesis
Interventions: Gastric emptying test; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastric Antral Vascular Ectasia, Cirrhosis, Chronic Kidney Disease
Interventions: Gastric Emptying Breath Test; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 19 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip

High Resolution Gastric Mapping and Gastroduodenal Manometry

Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT)

Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure

Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis

Endoscopic Metabolic and Bariatric Therapies

Vagal Nerve Stimulation for Gastroparesis

Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure

Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis

13C-Spirulina Nitrogen Content GEBT Study

Slowly Digestible Carbohydrates and the Ileal Brake

Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT)

Digestive Properties of Carbohydrate-based Foods

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity

GEBT Lot-to-Lot and Biological Variability

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

Development of a Noninvasive Metric to Measure Small Bowel Sensation - The Small Intestine Stress Test

Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus

Effects of Oxybutynin Topical Gel on Gastric Emptying

Dietary, Medication, and Endoscopic Interventions for Post-Bariatric Hypoglycemia

Atrial Fibrillation Ablation on Gastric Motility "The AF Gut Study"

Validation of Plant-Based Vegan Meal for Gastric Emptying Testing in 10 Healthy Subjects

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias